Predictors of response to antidepressant drug therapy;Pradiktive Faktoren fur den Therapieerfolg beim depressiven Syndrom

Nervenarzt

Volumn 68, Issue 1, 1997, Pages 62-66

  Faltermaier Temizel, M ^a,b   Laakmann, G ^a   Baghai, T ^a   Kuhn, K ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

course of recovery; depressive disorder; drug regimen; response prediction; therapy monitoring

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DIAZEPAM; ETOPERIDONE; LITHIUM; LORAZEPAM;

ADULT; ARTICLE; DEPRESSION; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; SLEEP DEPRIVATION; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG MONITORING; MIDDLE AGED; PERSONALITY TEST; PROGNOSIS; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; HUMANS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0031055802     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050097     Document Type: Article

References (37)

1. Beck AT (1983) Cognitive therapy of depression: new perspectives. In: Clayton PJ, Barren JE (eds) Treatment of depression. old controversies and new approaches Raven Press, New York, pp 265-284
2. Bielski RJ, Friedel RO (1976) Prediction of tricyclic antidepressant response: a critical review. Arch Gen Psychiatry 33: 1479-1489
3. Cloninger CR, Svrakic DM, Przybeck TR (1993) A psychobiological model of temperament and character. Arch Gen Psychiatry 50- 975-990
4. Fairchild CJ, Rush AJ, Davidson RK, Giles DE, Khatami M (1986) Which depressions respond to placebo? Psychiatry Res 18: 217-226
5. Fähndrich E (1990) Biologische Prädiktoren fur eine erfolgreiche antidepressive medikamentose Behandlung. In: Möller H-J (Hrsg) Therapieresistenz unter Antidepressiva-Behandlung. Springer Berlin Heidelberg New York, S 43-57
6. Galinowski A (1991) Facteurs somatiques et biologiques prédisant une réponse aux antidépresseurs. Encéphale 17: 387-390
7. Georgotas A, McCue RE, Cooper T, Chang I, Mir P, Welkowitz J (1987) Clinical predictors of response to antidepressants in elderly patients. Biol Psychiatry 22: 733-740
8. Haberman SJ (1973) The analysis of residuals in cross-classified tables. Biometrics 29: 205-220
9. Hamilton M (1960) A rating scale for depression, J Neurol Neurosurg Psychiatry 23: 56-62
10. Hamilton M (1976) 048 HAMA. Hamilton anxiety scale. In: Guy W (ed) ECDEU Assessment manual for psychopharmacology, rev edn. Rockville, Maryland, pp 193-198
11. Heimchen H (1990) Gestuftes Vorgehen bei Resistenz gegen Antidepressiva-Therapie. In: Möller H-J (Hrsg) Therapieresistenz unter Antidepressiva-Behandlung. Springer. Berlin Heidelberg New York, S 237-250
12. Janke W, Debus G (1978) Die Eigenschaftsworterliste (EWL-K) - Ein Verfahren zur Erfassung der Befindlichkeit. Hogrefe, Göttingen
13. Joyce PR (1994) Predictors for treatment response and treatment selection. Cur Opin Psychiatr 7: 26-29
14. Joyce PR, Mulder RT, Cloninger CR (1994) Temperament predicts clomipramine and desipramine response in major depression. J Affect Disord 30: 35-46
15. Joyce PR, Paykel ES (1989) Predictors of drug response in depression. Arch Gen Psychiatry 46: 89-99
16. Katz MM, Koslow SH, Maas JW, Frazer A, Bowden CL, Casper R, Croughan J, Kocsis J, Redmond EJ (1987) The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med 17: 297-309
17. Katz MM, Koslow SH, Maas JW, Frazer A, Kocsis J, Secunda S, Bowden CL, Casper RC (1991) Identifying the specific clinical actions of amitriptyline: interrelationship of behaviour, affect and plasma levels in depression. Psychol Med 21: 599-611
18. Khan A. Brown WA (1991) Who should receive antidepressants: suggestions from placebo treatment. Psychopharmacol Bull 27: 271-274
19. Laakmann G (1981) Studienmodell zur Prüfung von Psychopharmaka in der ärztlichen Praxis. Z Allgemeinmed 57: 103-111
20. Laux G (1990) Dosiserhohung, Titration eines optimalen Wirkspiegels und Infusionstherapie als effiziente Möglichkeiten der Behandlung therapieresistenter Depressionen mit Antidepressiva. In: Moller H-J (Hrsg) Therapieresistenz unter Antidepressiva. Springer, Berlin Heidelberg New York, S 99-112
21. Levine J, Raskin A (1974) Predicting treatment responsiveness-resistiveness in a population of depressed patients. Pharmacopsychiatry 7: 217-222
22. Möller HJ, Fischer G, Zerssen D von (1990) Vorhersage des Therapieerfolges unter Akutbehandlung mit Antidepressiva: Ergebnisse einer empirischen Untersuchung an 159 stationär behandelten Patienten mit endogener Depression. In: Möller H-J (Hrsg) Therapieresistenz unter Antidepressiva. Springer, Berlin Heidelberg New York, S 14-32
23. Möller H-J (1991) Therapieresistenz auf Antidepressiva. Nervenarzt 62: 658-669
24. National institut of mental health (1976) 028 CGI. Clinical global impressions. In: Guy W (ed) ECDEU assessment manual for psychopharmacology, rev edn. Rockville. Maryland, pp 179-192
25. Quitkin FM, Rabkin JG, Ross D, Stewart JW (1984) Identification of true drug response to antidepressants. Use of pattern analysis. Arch Gen Psychiatry 41: 782-786
26. Quitkin FM, Rabkin JD, Markowitz JM, Stewart JW, McGrath PJ, Harrison W (1987) Use of pattern analysis to identify true drug response. A replication. Arch Gen Psychiatry 44: 259-264
27. Ribeiro SC, Tandon R, Grunhaus L, Greden JF (1993) The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 150: 1618-1629
28. Rose JT, Westhead TT (1967) Treatment of depression. A comparative trial of imipramine and desipramine. Br J Psychiatry 113: 659-665
29. Rush AJ, Roffwarg HP, Giles DE, Schiesser MA, Fairchild C, Tarell J (1983) Psychobiological predictors of antidepressant drug response. Pharmacopsychiatr 16: 192-194
30. Schmauss M, Erfurth A (1993) Prädiktion des antidepressiven Behandlungserfolgs - kritische Übersicht und Perspektiven. Fortschr Neurol Psychiatr 61: 274-283
31. Small JG, Milstein V, Kellams JJ, Small IF (1981) Comparative onset of improvement in depressive symptomatology with drug treatment, electroconvulsive therapy, and placebo. J Clin Psychopharmacol 1 [Suppl]: 62S-69S
32. Sotsky SM, Glass DR, Shea MT, Pilkonis PA, Collins JF, Elkin I, Watkins JT, Imber SD, Leber WR, Moyer J, Oliven ME (1991) Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH treatment of depression collaborative research program. Am J Psychiatry 148: 997-1008
33. Stassen HH, Angst J, Delini-Stula A (1994) Severity at baseline and onset of improvement in depression. Meta-analysis of imipramine and moclobemide versus placebo. Eur Psychiatry 9: 129-136
34. Woggon B (1983) Prognose der Psychopharmakotherapie. Enke, Stuttgart
35. Woggon B (1990) Fruhansprechen auf Antidepressiva. die prognostische Bedeutung der Probetherapie. In: Möller H-J (Hrsg) Therapieresistenz unter Antidepressiva. Springer, Berlin Heidelberg New York, S 34-38
36. Woggon B (1992) Prädiktoren für das Ansprechen auf Psychopharmaka. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuro-Psychopharmaka, Bd 1. Springer, Berlin Heidelberg New York, S 475-484
37. Zung WWK (1976) Self-rating depression scale. In: Guy W (ed) ECDEU assessment manual for psychopharmacology, rev edn. Rockville. Maryland, pp 333-336